Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669982 | SCV000794788 | uncertain significance | Enhanced S-cone syndrome; Retinitis pigmentosa 37 | 2017-10-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002532094 | SCV003467149 | uncertain significance | not provided | 2022-07-05 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with histidine at codon 226 of the NR2E3 protein (p.Arg226His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs544290323, gnomAD 0.03%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with NR2E3-related conditions. ClinVar contains an entry for this variant (Variation ID: 554361). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Breakthrough Genomics, |
RCV002532094 | SCV005193909 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Institute of Human Genetics, |
RCV004817893 | SCV005073165 | uncertain significance | Retinal dystrophy | 2023-01-01 | no assertion criteria provided | clinical testing |